WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2017

Feb 16, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2017-02-14

Reporting Person: Favorite Annette F (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-02-14	Common Stock	A	520.00	$86.93	Acquired	6170.9727	Direct
2017-02-14	Common Stock	A	2372.00	$86.93	Acquired	2388.8147	Indirect

Footnotes

F1: Shares represent the portion of the Performance Share Unit Award granted in 2014 that have vested for period 13.

F2: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.

F3: Bonus and incentive shares granted on 02/14/2017.